Sentinel Node Biopsy in Breast Cancer: Omission of Axillary Clearance After Macrometastases. A Randomized Trial.

NAActive, not recruitingINTERVENTIONAL
Enrollment

2,700

Participants

Timeline

Start Date

January 27, 2015

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2031

Conditions
Breast Cancer
Interventions
PROCEDURE

Omission of axillary clearance

The intervention is the omission of completion axillary clearance after the detection of sentinel node macrometastasis

Trial Locations (33)

Unknown

Sygehus Sonderjylland, Aabenraa

Aalborg University Hospital, Aalborg

Aarhus University Hospital, Aarhus

Rigshospitalet, Copenhagen

Sydvestjysk Sygehus, Esbjerg

Sygehus Lillebaelt, Lillebaelt

Odense University Hospital, Odense

Randers Regionshospitalet, Randers

Regionshospitalet Viborg, Viborg

Athens University Hospital, Athens

Gävle sjukhus, Gävle

Sahlgrenska University Hospital, Gothenburg

Hallands sjukhus, Halmstad

Helsingborg lasarett, Helsingborg

Länssjukhuset Ryhov, Jönköping

Kalmar sjukhus, Kalmar

Blekinge sjukhuset, Karlskrona

Karlstad sjukhus, Karlstad

Central Hospital Kristianstad, Kristianstad

Linköping University Hospital, Linköping

Malmö/Lund University Hospital, Lund

Örebro University Hospital, Örebro

Skaraborgs sjukhus, Skövde/Lidköping

Karolinska University Hospital, Stockholm

Southern Gerenal Hospital, Stockholm

St. Görans Hospital, Stockholm

Sundsvall länssjukhus, Sundsvall

Uddevalla sjukhus, Uddevalla

Umeå University Hospital, Umeå

Akademiska Sjukhuset, Uppsala

Varbergs sjukhus, Varberg

Västerås Central Hospital, Västerås

Västervik Hospital, Västervik

All Listed Sponsors
collaborator

The Swedish Research Council

OTHER_GOV

collaborator

Swedish Cancer Foundation

OTHER

collaborator

Nordic Cancer Union

OTHER

lead

Karolinska Institutet

OTHER